3M Tegaderm CHG, Chlorhexidine Gluconate I.V. Securement Dressing, REF 1658R
FDA Device Recall #Z-0038-2025 — Class II — August 14, 2024
Recall Summary
| Recall Number | Z-0038-2025 |
| Classification | Class II — Moderate risk |
| Date Initiated | August 14, 2024 |
| Status | Ongoing |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | 3M Company - Health Care Business |
| Location | Saint Paul, MN |
| Product Type | Devices |
| Quantity | 10,000 units |
Product Description
3M Tegaderm CHG, Chlorhexidine Gluconate I.V. Securement Dressing, REF 1658R
Reason for Recall
Contamination with foreign substance matter
Distribution Pattern
International distribution to the country of South Korea.
Lot / Code Information
UDI/DI 10707387802223 (carton), UDI/DI 30707387802227 (each), Lot Number 33WWRRR
Other Recalls from 3M Company - Health Care Business
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-0743-2025 | Class II | Clarity Precision Grip Attachments, for use in ... | Nov 22, 2024 |
| Z-1633-2024 | Class II | 3M Durapore Surgical Tape, Catalog Number 1538-118 | Mar 20, 2024 |
| Z-1475-2024 | Class II | 3M Tube Securement Device, Small, 1.7 IN/PO x 2... | Feb 20, 2024 |
| Z-1170-2024 | Class II | 3M Specialty Blade Assembly, REF 9660,70-2011-8... | Jan 12, 2024 |
| Z-1169-2024 | Class II | 3M Specialty Blade Assembly, REF 9660,70-2011-8... | Jan 12, 2024 |
Frequently Asked Questions
Sterility recalls for medical devices vary in severity. If you have already had a procedure using a potentially non-sterile device, contact your healthcare provider immediately — you may need monitoring for signs of infection. Symptoms to watch for include fever, redness or swelling at the surgical site, unusual pain, or discharge. For devices that have not yet been used, they should be quarantined and returned to the manufacturer per the recall notice. Non-sterile implants can cause serious infections; early detection and treatment are critical.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.